FY2025 · ended Dec 31, 2025 · Revenue $2.91M · Filed Mar 31, 2026
Osr Health, Inc. (OSRH) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.9 million and a net loss of $27.1 million. As of Jun 30, 2026 it held $1.5 million in cash and investments and $2.7 million in total debt.
Revenue (TTM)
$1.81M
Net income (TTM)
$-14.91M
Operating cash flow (TTM)
$-7.20M
-409.4% vs year-ago TTM
Free cash flow
—
EPS (TTM)
$-0.34
Dividend per share
None
Shares outstanding
33.12M
+71.8% vs prior year
Net cash
$-1.18M
as of Jun 30, 2026
Operating margin
-933.7%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OSRH (OTC), OSRHW (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bellevue, WA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1840425
- Former names
- OSR Holdings, Inc. (until Jun 11, 2026); Bellevue Life Sciences Acquisition Corp. (until Feb 13, 2025)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
|---|---|---|---|
| Revenue | $2.9M | — | — |
| Operating income | -$18.3M | — | -$35,388 |
| Net income | -$27.1M | $403,780 | -$35,388 |
| Diluted EPS | -$0.80 | $0.05 | — |
| Operating cash flow | -$4.3M | -$818,766 | -$4,235 |
| Total assets | $171.2M | $36.6M | $1.2M |
| Total liabilities | $44.2M | $4.1M | $1.3M |
| Stockholders' equity | $127.0M | — | — |
| Cash and investments | $1.7M | $15,419 | $124,501 |
| Total debt | $2.4M | — | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Oct 28, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Material agreement
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Aug 28, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Other events
|
Aug 25, 2026 | Aug 25, 2026 |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Aug 19, 2026 | Aug 19, 2026 |
All 226 Osr Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.